Compare UNB & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNB | SEER |
|---|---|---|
| Founded | 1891 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.6M | 111.4M |
| IPO Year | 1999 | 2020 |
| Metric | UNB | SEER |
|---|---|---|
| Price | $23.88 | $1.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.3K | ★ 414.5K |
| Earning Date | 04-20-2026 | 05-29-2026 |
| Dividend Yield | ★ 6.14% | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | ★ 1.82 | N/A |
| Revenue | N/A | ★ $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $25.90 |
| P/E Ratio | $12.91 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $20.65 | $1.62 |
| 52 Week High | $34.85 | $2.41 |
| Indicator | UNB | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 45.85 | 44.10 |
| Support Level | $23.63 | $1.71 |
| Resistance Level | $25.15 | $1.97 |
| Average True Range (ATR) | 0.73 | 0.10 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 35.39 | 30.68 |
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.